CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery

Name: CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery
License: Public Domain

Jonsson Comprehensive Cancer Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

melanoma (skin)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 307322
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.